Researchers tracked nearly 1,000 SAVR patients, presenting eight-year data at the Heart Valve Society’s annual meeting in Cairo, Egypt. 

The 55-year-old patient woke up experiencing chest pain one morning and an ambulance was called. He was dead just a few hours later. His family's lawsuit argued that delays in care, communication errors and other issues were directly responsible for his death.

AI may finally end the paper chase caused by prior authorization. Or it may worsen it. 

Coronary artery disease is both underdiagnosed and undertreated in women, and they often receive less guideline-recommended care than men. Why do these disparities persist? And what can today’s healthcare providers do to bring about change?

As AI continues its march through healthcare organizations around the world, the notion that it will replace the sector’s human workers fades but does not disappear. 

Cardiovascular Business is thrilled to unveil the Forty Under 40 Class of 2025.  

We asked readers to nominate individuals who are already making a major impact on the world of cardiovascular health at a young age. We wanted to hear about your best, your brightest, your most radical thinkers; the people who are never satisfied by something being “good enough” or “how it’s always been done.”   

Contrary to popular misgivings, AI may be improving the human touch in healthcare. 

The National Academy of Medicine considers some pertinent ins and outs of GenAI.